A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
DFT-QSAR and Molecular Docking Studies on 1,2,3-Triazole-Dithiocarbamate Hybrids as Potential Anticancer Agents
2019
Physical Science International Journal
Recently, considerable attention has been drawn on the search for novel anticancer drugs in order to improve survival rates and wellbeing of cancer patients. 1,2,3-triazole is an attractive scaffold possessing diverse biological activities. The quantitative structure-activity relationship (QSAR) is a powerful computational tool which has widened the scope of rational drug design, as well as the search for the mechanisms of drug actions. A series of novel 1,2,3-triazole-dithiocarbamate hybrids
doi:10.9734/psij/2018/46207
fatcat:yqox3zzmszgd5etlslcz5n7oaq